PAR 2.04% 24.0¢ paradigm biopharmaceuticals limited..

The issue with GGs post is that it missed the key point in...

  1. 9,819 Posts.
    lightbulb Created with Sketch. 1249
    The issue with GGs post is that it missed the key point in latest update -- they may still apply for fast track designation when the time is right. After IND and perhaps on NDA

    Simon nor any PR department is in a position to respond to every skidish shareholder. Delays see frustration and a correlating increase in queries.

    PARs issues to date revolve around the moving goal posts in terms of how they plan to bring Ipps to market. This probably shows an element of inexperience but also flexibility. Read what PR initially planned to what they're now looking at achieving in TAM. Safety and durable trials will allow it the be easily prescribed by GPs and possibly self administered. If they pull it off your family and friends will all be quite envious
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
-0.005(2.04%)
Mkt cap ! $83.95M
Open High Low Value Volume
24.5¢ 24.5¢ 23.3¢ $74.59K 314.3K

Buyers (Bids)

No. Vol. Price($)
6 28833 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 21738 1
View Market Depth
Last trade - 16.10pm 02/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.